Benitec Biopharma Inc. ( BNTC) - Key Metrics
BNTC Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q4 | $0 | -$0.28 | -$0.11 | -$0.11 |
| 2026Q3 | $0 | -$0.24 | -$0.10 | -$0.10 |
| 2026Q2 | $0 | -$0.26 | -$0.08 | -$0.08 |
| 2026Q1 | $0 | -$0.22 | -$0.08 | -$0.08 |
| 2025Q4 | $0.02 | -$0.45 | -$0.24 | -$0.24 |
BNTC Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q4 | 0% | -12.39 |
| 2026Q3 | 0% | -11.09 |
| 2026Q2 | 0% | -12.95 |
| 2026Q1 | 0% | -16.70 |
| 2025Q4 | 0% | -7.50 |
BNTC
Price: $8.63
52 week price:
Earnings Per Share: -0.98 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 208500
Ebitda: -11.8 millionMarket Capitalization: 319.3 million